# Tamoxifen in Treating Patients With Primary Liver Cancer

> **NCT00003424** · PHASE3 · COMPLETED · sponsor: **National Medical Research Council (NMRC), Singapore** · enrollment: 300 (estimated)

## Conditions studied

- Liver Cancer

## Interventions

- **DRUG:** tamoxifen citrate

## Key facts

- **NCT ID:** NCT00003424
- **Lead sponsor:** National Medical Research Council (NMRC), Singapore
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-04
- **Primary completion:** 2000-06
- **Final completion:** 2009-08
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003424, "Tamoxifen in Treating Patients With Primary Liver Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*